News
06/08/2021
GPB Scientific Gets $18M Infusion
As reported online by Richmond BizSense, GPB Scientific closed on an $18 million funding round. The money will help the company roll out its Curate cell processing system, which separates and extracts cells from blood samples to create therapies for cancer and other diseases. Funding came by way of Amgen Ventures and Vensana Capital (firms …
06/08/2021
ReAlta Life Sciences Receives $3.2 Million Grant from Virginia Catalyst to Accelerate Trial for the Treatment of Acute Lung Injury Due to COVID-19
ReAlta Life Sciences has received a $3.2 million grant award from The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), to accelerate the Company’s Phase 1b clinical trial evaluating RLS-0071 for the treatment of acute lung injury (ALI) due to COVID-19. The award, which is granted to Virginia companies to support …
05/28/2021
Study Upgrades of the Largest Databases of Neuronal Types
A study led by researchers from the Institute Cajal of Spanish Research Council (CSIC) in Madrid, Spain in collaboration with the Bioengineering Department of George Mason University in Virginia, U.S. has updated one of the world’s largest databases on neuronal types, Hippocampome.org. The study, which is published in the journal PLOS Biology, represents the most …
05/26/2021
Southern Spine Announces John E. Hart as President and Chief Executive Officer
Southern Spine, LLC, an ISO 13485:2003 certified manufacturer of implants and instruments for spinal surgery, announced that John E Hart has been named as President and Chief Executive Officer to lead the company. Hart has more than 35 years of executive leadership experience in the medical device, life science and biologics fields serving in general …
05/25/2021
CIT Announces Key Additions to GAP Funds Investment Team
The Center for Innovative Technology (CIT), the nonprofit operations arm of the Virginia Innovation Partnership Authority (VIPA), announced that CIT GAP Funds has added two new Investment Associates to its team: Dustin Dunbar and Anthony Obi Jr. As Investment Associates, Dunbar, and Obi will support CIT GAP Funds activity including deal sourcing and due diligence …
05/25/2021
Are you a medical professional? KinergyCare needs your help!
KinergyCare is a Virginia-based startup and a Virginia Bio member that is requesting feedback from this community on a care coaching and coordination approach that focuses on the needs of patients with cardiovascular disease. We’re pioneering a new approach that combines patient data on health capabilities with a personalized intervention based on behavioral science. The result should …
05/24/2021
Albemarle High School Teen Competes for Virginia
Virginia Bio and the Virginia Bioscience Foundation have named Albemarle High School’s, Meenakshi “Meena” Ambati, as the winner of the 2021 Virginia BioGENEius Challenge, the premier competition for high school students that recognizes outstanding research and innovation in the biotechnology field. As the Virginia BioGENEius finalist, Meena will attend the 2021 BIO Digital Conference, where …
05/18/2021
ReAlta Life Sciences Expands Phase 1 Clinical Trial of RLS-0071
ReAlta Life Sciences (“ReAlta”), Inc., a company addressing life-threatening diseases through harnessing the power of the immune system, today announced that it has received a no objection letter (NOL) from Health Canada to an Amendment of the Company’s Phase 1 clinical trial of RLS-0071 in healthy volunteers. The study design has been modified to add …
05/18/2021
Children’s National spinout AlgometRx developed a device that measures pain
A longtime pediatric anesthesiologist at Children’s National Hospital, Dr. Julia Finkel has long wanted a more objective way to measure how much pain patients are feeling. “For pain, we do it very empirically,” Dr. Finkel said. “The patient says they hurt, we give them a drug. They either feel better or they don’t…It’s done in …
05/17/2021
Landos Biopharma and LianBio Announce Exclusive Collaboration and License Agreement
Landos Biopharma, Inc, a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for patients with autoimmune diseases, and LianBio, a biotechnology company dedicated to bringing paradigm-shifting medicines to patients in China and other major Asian markets, today announced an exclusive collaboration and license agreement for the development and commercialization of omilancor and NX-13 …
05/10/2021
Landos Biopharma Announces First Patient Dosed in a Phase 2 Study of Omilancor for Crohn’s Disease
Landos Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for patients with autoimmune diseases, announced that the Company has dosed the first patient in a Phase 2 study of omilancor, Landos’ novel, orally administered, gut-restricted LANCL2 agonist, for the treatment of moderate-to-severe Crohn’s disease (CD). “We are extremely proud of …
05/07/2021
BIO-CAT Grows in Zion Crossroads
BIO-CAT, Inc., a biotechnology company that specializes in enzymes and other advanced microbial solutions, plans to add at least 30,000 square feet to its fermentation facilities in Zion Crossroads. The expansion is projected to start in 2022. The company will add several new jobs and is considering building another 30,000-square-foot section in a second phase. …
05/06/2021
Contraline, Inc. Expands Board of Directors
Contraline, Inc., a venture-backed medical device company devoted to providing men and couples with long-lasting, safe, and effective male contraception, has appointed medical device industry executive Martin Emerson to its Board of Directors.
05/04/2021
AMPAC plans $25 million expansion at is Petersburg plant, adding 150 new jobs
AMPAC Fine Chemicals announced a $25 million expansion of its operations that is expected to add more than 150 new jobs. The California-based company is a top U.S. manufacturer of active pharmaceutical ingredients. The plant in Petersburg previously was owned by Boehringer Ingelheim Chemicals Inc., which closed it in 2014, but AMPAC reopened the site …
05/04/2021
ivWatch Awarded Patient Safety Solutions Agreement with Premier, Inc.
ivWatch, LLC has been awarded a group purchasing agreement for Patient Safety Solutions with Premier, Inc. to provide more than 4,000 Premier member hospitals with greater access to the only continuous peripheral IV (PIV) site monitoring technology available in the market. The three-year agreement underscores the importance of detecting IV infiltration and extravasation events early …
05/03/2021
Aditxt to Establish State-of-the-Art Immune Monitoring Center in Virginia Bio+Tech Park »
Aditxt (Aditx Therapeutics, Inc.) a biotech innovation company focused on improving the health of the immune system, announced plans to build a high-capacity AditxtScore™ Center in the Virginia Bio+Tech Park in Richmond, VA in the second half of 2021.
05/03/2021
RIVANNA® Announces Alliance With Tri-anim Health Services
RIVANNA®, developers of world-first, imaging-based medical solutions, announced they have entered into a partnership with Tri-anim Health Services, a specialty distributor of respiratory, anesthesia, and critical-care supplies, to represent and distribute the Accuro® portfolio of products in the United States.
05/03/2021
Aditxt to Establish State-of-the-Art Immune Monitoring Center in Virginia Bio+Tech Park
Aditxt (Aditx Therapeutics, Inc.) a biotech innovation company focused on improving the health of the immune system, announced plans to build a high-capacity AditxtScore™ Center in the Virginia Bio+Tech Park in Richmond, VA in the second half of 2021. Aditxt is targeting a capital investment of $31.5 million over three years to scale up its …
05/03/2021
RIVANNA® Announces Alliance With Tri-anim Health Services
RIVANNA®, developers of world-first, imaging-based medical solutions, announced they have entered into a partnership with Tri-anim Health Services, a specialty distributor of respiratory, anesthesia, and critical-care supplies, to represent and distribute the Accuro® portfolio of products in the United States. RIVANNA announced a partnership with Tri-anim Health Services Tri-anim is a natural distribution choice for …
05/03/2021
Children’s National Research & Innovation Campus Welcomes New Resident Company, AlgometRx to JLABS
AlgometRx Inc., a Children’s National spinout company developing a handheld device to objectively measure pain by pupillary response, will relocate to Johnson & Johnson Innovation – JLABS @ Washington, DC on the Children’s National Research & Innovation Campus.
04/30/2021
HemoShear Therapeutics Hiring Senior Assay Scientist
ABOUT THE JOB SUMMARY OF POSITION: The Lab Scientist will design, develop and perform biological assays while also analyzing data and presenting their results as a member of HemoShear’s proprietary and collaborative partnership drug discovery program teams.
04/30/2021
CorVista Health is Hiring Chief of Staff
This role is an integral part of the growth and success of a dynamic, fast paced startup at the cusp of commercialization. We seek a strong Chief of Staff who will work closely with the CEO on execution of all projects associated with the success of the company, from administrative to HR support, stakeholder communications,
04/29/2021
ReAlta Life Sciences Closes $20M Series A3 Financing to Advance Multiple Programs into Phase 2 Trial
ReAlta Life Sciences, Inc., announced that the Company has successfully closed a Series A3 financing of $20 million. The financing was led by Marathon Pharma, with support from existing Series A investors and new, undisclosed investors.
04/27/2021
ODU Awarded a $1.6M NIH Grant to Increase the Diversity of Biomedical Researchers »
The first cohort of the Graduate Research Training Initiative for Student Enhancement (G-RISE) will arrive at Old Dominion University this summer on their path to make a lasting impact in the field of biomedical research. G-RISE is designed increase the diversity of biomedical researchers by attracting underrepresented students from minority, military, socioeconomically disadvantaged and disability …